A Study of VIS410 to Assess Safety and Pharmacokinetics

Inclusion Criteria: * Healthy volunteers * Body mass index between 18 and 33 kg/m2, inclusive * Normal labs * Volunteers agree to use acceptable contraceptive measures Exclusion Criteria: * Prior receipt of antibody or biologic therapy * History of cancer, heart disease, diabetes, respiratory condition (eg asthma), autoimmune disorder, blood dyscrasias * Any chronic condition requiring daily prescription or over the counter medication * History of a previous severe allergic reaction * Drug or alcohol abuse within previous 12 months * Positive serology for human immunodeficiency virus (HIV) antibody, hepatitis C virus (HCV) antibody or hepatitis B surface antigen (HBsAg) * Positive pregnancy test * Breast feeding * Positive drug or alcohol test at screening or check-in * Receipt of licensed vaccine (within 30 days) or other investigational product within 30 days or 5 half-lives, whichever is longer, before study product administration